Skip to main content
. 2025 Aug 5;18:51. doi: 10.1186/s13040-025-00466-5

Table 2.

Repurposed candidate drugs for AD identified using ESCARGOT on AlzKB. These drugs are novel repurposing candidate drugs as they have neither been used as treatments for Alzheimer’s disease nor reported in previous studies

Drug Filtering DrugClass AD Genes ATC classification (Level 1) ATC classification (Level 2)
Epirubicin 2-hop Pathway Anthracyclines Topoisomerase Inhibitors IL1B, APOE Antineoplastic and immunomodulating agents Antineoplastic agents
Vemurafenib 2-hop Pathway Cytochrome P450 1A2 Inhibitors P-Glycoprotein Inhibitors Protein Kinase Inhibitors CASP3, ADAM10 Antineoplastic and immunomodulating agents Antineoplastic agents
Vitamin A 2-hop BodyPart Vitamin A DPYSL2, APP PPARG, HMOX1 Sensory organs Ophthalmologicals
Fulvestrant 2-hop BodyPart Estrogen Receptor Antagonists Selective Estrogen Receptor Modulators WWOX, ESR1, HMOX1 Antineoplastic and immunomodulating agents Antineoplastic agents